FATE FATE THERAPEUTICS INC: institutional ownership and insider trading
156 funds reported holding $206M of FATE THERAPEUTICS INC in their latest 13F filings; in Q2 2026 funds net sold $5.68M, with 31 new positions and 30 funds selling out; over the last 12 months insiders bought $0 and sold $323K on the open market.
Famous investors holding FATE
- Two Sigma (Two Sigma Investments): $9.69M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $8.05M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $6.57M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.95M, 0.0% of the portfolio
Largest institutional holders of FATE
- Redmile Group, LLC — $34.8M
- BlackRock, Inc. (BLK) — $19.7M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $12.3M
- VANGUARD CAPITAL MANAGEMENT LLC — $12.0M
- ACADIAN ASSET MANAGEMENT LLC — $11.7M
- AQR CAPITAL MANAGEMENT LLC — $10.4M
- TWO SIGMA INVESTMENTS, LP — $9.69M
- JOHNSON & JOHNSON (JNJ) — $9.12M
- VANGUARD GROUP INC — $8.82M
- RENAISSANCE TECHNOLOGIES LLC — $8.05M
Recent FATE insider trades
- Aug 4, 2026: Valamehr Bahram sold 43,947 shares ($108K)
- Aug 4, 2026: Tahl Cindy sold 38,800 shares ($95.4K)
- May 20, 2026: Valamehr Bahram sold 28,946 shares ($54.4K)
- May 20, 2026: Tahl Cindy sold 25,590 shares ($48.1K)
5%+ owners
- Redmile Group, LLC: 14.9% (Schedule 13D/A, filed Apr 22, 2026)